MARKET

PKI

PKI

Perkinelmer
NYSE
124.00
-5.61
-4.33%
After Hours: 124.00 0 0.00% 16:18 10/07 EDT
OPEN
127.81
PREV CLOSE
129.61
HIGH
128.66
LOW
123.62
VOLUME
898.31K
TURNOVER
0
52 WEEK HIGH
203.16
52 WEEK LOW
116.18
MARKET CAP
15.65B
P/E (TTM)
22.85
1D
5D
1M
3M
1Y
5Y
Analyst Ratings for PerkinElmer
PerkinElmer (NYSE:PKI) has observed the following analyst ratings within the last quarter:
Benzinga · 1d ago
Barclays Maintains Underweight on PerkinElmer, Lowers Price Target to $120
Barclays analyst Luke Sergott maintains PerkinElmer (NYSE:PKI) with a Underweight and lowers the price target from $140 to $120.
Benzinga · 1d ago
Barclays Adjusts PerkinElmer's Price Target to $120 From $140, Reiterates Underweight Rating
Barclays Adjusts PerkinElmer's Price Target to $120 From $140, Reiterates Underweight Rating
MT Newswires · 1d ago
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
Benzinga · 09/27 18:14
FDA updates COVID-19 test policy to cut emergency use requests
Revising its COVID-19 test policy, the U.S. Food and Drug Administration (FDA) said Tuesday that the agency would review only a small number of new emergency use authorization (EUA) requests for diagnostic tests.Instead, the FDA urges deve...
Seekingalpha · 09/27 15:47
PerkinElmer Unveils Industry-first Cell Analysis Solution to Streamline Cell and Gene Therapy Research and Manufacturing
WALTHAM, Mass., September 26, 2022--PerkinElmer, Inc., (NYSE: PKI), a global leader committed to innovating for a healthier world, today launched the Cellaca® PLX Image Cytometry System, a first-of-its-kind benchtop platform that enables researchers to ass...
Business Wire · 09/26 11:11
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns
The World Health Organization (WHO) warned that it struggles to identify and
Benzinga · 09/23 12:02
PerkinElmer gets FDA approval for T-Cell Select kit to automate TB test
PerkinElmer's (NYSE:PKI) Oxford Immunotec <a href="https://seeki...
Seekingalpha · 09/22 12:54
More
About PKI
PerkinElmer, Inc. is a provider of products, services and solutions for the diagnostics, life sciences and applied markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides products and services targeted towards the life sciences and applied markets. The Diagnostics segment develops diagnostics, tools and applications focused on clinically oriented customers, especially within the reproductive health, immunodiagnostics and applied genomics markets. The Company provides early detection for genetic disorders from pregnancy to early childhood, and infectious disease testing for the diagnostics market. It offers its products under various brand names, including AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific, BoBs, chemagic, Chitas, Datalytix, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROline, EUROPattern, FragilEase, Genoglyphix, GSP, and others.

Webull offers kinds of PerkinElmer, Inc. stock information, including NYSE:PKI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PKI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PKI stock methods without spending real money on the virtual paper trading platform.